| Medical Center Pharmacy | |
| 221 Boston Rd, North Billerica, Massachusetts 01862 | |
| (978) 663-6583 |
| Name | Medical Center Pharmacy |
|---|---|
| Organization Name | Mccormacks Drug Inc |
| Location | 221 Boston Rd, North Billerica, Massachusetts 01862 |
| Type | Pharmacy |
| Phone | (978) 663-6583 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Matrixx Initiatives, Inc. and H.I.G. Capital, LLC ("H.I.G."), a leading global private investment firm, today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relating to the previously announced acquisition of all outstanding shares of common stock of the Company by affiliates of H.I.G. Accordingly, the condition with respect to the expiration of the applicable waiting periods under the HSR Act has been satisfied.
Why do people become physically weaker as they age? And is there any way to slow, stop, or even reverse this process, breaking the link between increasing age and frailty?
A new cost-effectiveness analysis has led researchers from Duke University Medical Center and the Veterans Affairs (VA) Palo Alto Health Care System to recommend that routine voluntary screening for HIV
Using two drugs was no more effective than a single drug in slowing disease progression in people with autosomal dominant polycystic kidney disease (ADPKD), according to two studies funded by the National Institutes of Health. One of the studies also showed that rigorous blood pressure treatment slowed growth of kidney cysts, a marker of ADPKD, but had little effect on kidney function compared to standard blood pressure treatment.
› Verified 1 days ago
| NPI Number | 1144770280 |
| Organization Name | MCCORMACKS DRUG INC |
| Doing Business As | MEDICAL CENTER PHARMACY |
| Type | Pharmacy |
| Address | 221 Boston Rd, North Billerica, MA 01862 |
| Phone Number | 978-663-6583 |
News Archive
Matrixx Initiatives, Inc. and H.I.G. Capital, LLC ("H.I.G."), a leading global private investment firm, today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relating to the previously announced acquisition of all outstanding shares of common stock of the Company by affiliates of H.I.G. Accordingly, the condition with respect to the expiration of the applicable waiting periods under the HSR Act has been satisfied.
Why do people become physically weaker as they age? And is there any way to slow, stop, or even reverse this process, breaking the link between increasing age and frailty?
A new cost-effectiveness analysis has led researchers from Duke University Medical Center and the Veterans Affairs (VA) Palo Alto Health Care System to recommend that routine voluntary screening for HIV
Using two drugs was no more effective than a single drug in slowing disease progression in people with autosomal dominant polycystic kidney disease (ADPKD), according to two studies funded by the National Institutes of Health. One of the studies also showed that rigorous blood pressure treatment slowed growth of kidney cysts, a marker of ADPKD, but had little effect on kidney function compared to standard blood pressure treatment.
› Verified 1 days ago
| NPI Number | 1821182171 |
| Organization Name | MCCORMACKS DRUG INC |
| Doing Business As | MEDICAL CENTER PHARMACY |
| Type | Pharmacy |
| Address | 221 Boston Rd, North Billerica, MA 01862 |
| Phone Number | 978-663-6583 |
News Archive
Matrixx Initiatives, Inc. and H.I.G. Capital, LLC ("H.I.G."), a leading global private investment firm, today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relating to the previously announced acquisition of all outstanding shares of common stock of the Company by affiliates of H.I.G. Accordingly, the condition with respect to the expiration of the applicable waiting periods under the HSR Act has been satisfied.
Why do people become physically weaker as they age? And is there any way to slow, stop, or even reverse this process, breaking the link between increasing age and frailty?
A new cost-effectiveness analysis has led researchers from Duke University Medical Center and the Veterans Affairs (VA) Palo Alto Health Care System to recommend that routine voluntary screening for HIV
Using two drugs was no more effective than a single drug in slowing disease progression in people with autosomal dominant polycystic kidney disease (ADPKD), according to two studies funded by the National Institutes of Health. One of the studies also showed that rigorous blood pressure treatment slowed growth of kidney cysts, a marker of ADPKD, but had little effect on kidney function compared to standard blood pressure treatment.
› Verified 1 days ago
News Archive
Matrixx Initiatives, Inc. and H.I.G. Capital, LLC ("H.I.G."), a leading global private investment firm, today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relating to the previously announced acquisition of all outstanding shares of common stock of the Company by affiliates of H.I.G. Accordingly, the condition with respect to the expiration of the applicable waiting periods under the HSR Act has been satisfied.
Why do people become physically weaker as they age? And is there any way to slow, stop, or even reverse this process, breaking the link between increasing age and frailty?
A new cost-effectiveness analysis has led researchers from Duke University Medical Center and the Veterans Affairs (VA) Palo Alto Health Care System to recommend that routine voluntary screening for HIV
Using two drugs was no more effective than a single drug in slowing disease progression in people with autosomal dominant polycystic kidney disease (ADPKD), according to two studies funded by the National Institutes of Health. One of the studies also showed that rigorous blood pressure treatment slowed growth of kidney cysts, a marker of ADPKD, but had little effect on kidney function compared to standard blood pressure treatment.
› Verified 1 days ago
Cvs Pharmacy #00131 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 210 Boston Rd, North Billerica, Massachusetts 01862 Phone: (978) 663-6616 | |
Medical Center Pharmacy Type: Pharmacy Location: 221 Boston Rd, North Billerica, Massachusetts 01862 Phone: (978) 663-6583 |